Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
ACS Chemical Neuroscience|March 24, 2017
Indole-Substituted Benzothiazoles and Benzoxazoles as Selective and Reversible MAO-B Inhibitors for Treatment of Parkinson's DiseaseMin-Ho Nam, Moosung Park, Hyeri Park, et al.
Science Advances|March 10, 2023
Integration of reconfigurable microchannels into aligned three-dimensional neural networks for spatially controllable neuromodulationSohyeon Jeong, Hyun Wook Kang, So Hyun Kim, et al.
Biosensors & Bioelectronics|July 8, 2021
Bimodal neural probe for highly co-localized chemical and electrical monitoring of neural activities in vivoUikyu Chae, Hyogeun Shin, Nakwon Choi, et al.
Journal of Medicinal Chemistry|February 2, 2026
Discovery of a Neuroprotective Diosgenin Derivative as a Novel Antidepressant Candidate Targeting LPS-TLR4 SignalingYounghun Yoo, Soo Yeon Baek, Hyelim Lee, et al.
Pain|May 1, 2025
Neuronal STING-GAT1 signaling maintains paclitaxel-induced neuropathic pain in the spinal cordThuy Linh Pham, Ramesh Sharma, Chiranjivi Neupane, et al.
Chinese Medicine|May 7, 2025
Invasive laser acupuncture targeting muscle: a novel approach to protect dopaminergic neurons and reduce neuroinflammation in a brain of Parkinson's disease modelHalin Jeon, Ju-Young Oh, Sora Ahn, et al.
Glia|December 14, 2019
Bestrophin1-mediated tonic GABA release from reactive astrocytes prevents the development of seizure-prone network in kainate-injected hippocampiSudip Pandit, Chiranjivi Neupane, Junsung Woo, et al.
Research Square|July 3, 2026
Basal forebrain parvalbumin neuron dysfunction links network oscillation deficits to hippocampal pathology in Alzheimer's diseaseEunjin Hwang, Hyun Soo Shim, Seung Chan Kim, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 19, 2021
A Multimodal Multi-Shank Fluorescence Neural Probe for Cell-Type-Specific Electrophysiology in Multiple Regions across a Neural CircuitNamsun Chou, Hyogeun Shin, Kanghwan Kim, et al.
The CRISPR Journal|February 22, 2022
CRISPR-Cas9 Gene Editing Protects from the A53T-SNCA Overexpression-Induced Pathology of Parkinson's Disease <i>In Vivo</i>Hyung Ho Yoon, Sunghyeok Ye, Sunhwa Lim, et al.
Pageof 7